Shares of healthcare giant CVS Health (NYSE: CVS) have been in a free fall this year. The company has failed to impress ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

Shares of CVS Health Corp. CVS inched 0.48% higher to $57.10 Thursday, on what proved to be an all-around positive trading ...

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...

Michigan’s pension bought Palantir, Intel, and CVS Health stock, while slashing an investment in Bristol Myers in the third ...

CVS Health stock (NYSE: CVS) is up over 10% on Wednesday ... This can be attributed to the loss of a large client and pharmacy client price improvements. The company's adjusted operating margin ...

Accordingly, despite the recent dip in share prices, this might not be the ideal time to invest in CVS Health. In fact, those who already own this stock may consider selling it ahead of its ...

Mizuho Securities has adjusted its price target for CVS Health (NYSE: NYSE:CVS), reducing it to $66 from the previous $73, while retaining an Outperform rating on the stock. The revision follows the ...